Attenuated Toxoplasma gondii ts-4 mutants engineered to express the Leishmania antigen KMP-11 elicit a specific immune response in BALB/c mice

Vaccine

Volumn 20, Issue 3-4, 2001, Pages 455-461

  Ramírez, José Robinson ^a,b   Gilchrist, Katherine ^a   Robledo, Sara ^a   Sepúlveda, Juan Carlos ^b   Moll, Heidrun ^b   Soldati, Dominique ^c   Berberich, Christof ^b  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

KMP 11; Leishmaniasis; Toxoplasma gondii

Indexed keywords

BACTERIAL ANTIGEN; CYTOPLASM PROTEIN; LEISHMANIA VACCINE; MEMBRANE PROTEIN; PLASMID VECTOR; PROTEIN KMP 11; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM MUTANT; CLONE; CONTROLLED STUDY; DISEASE CONTROL; DRUG FORMULATION; FEMALE; GENETIC ENGINEERING; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; LEISHMANIA MAJOR; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PARASITE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RECOMBINANT PLASMID; SKIN LEISHMANIASIS; TEMPERATURE SENSITIVE MUTANT; TOXOPLASMA GONDII; TREATMENT OUTCOME; VACCINATION; VACCINE PRODUCTION;

EID: 0035851346     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00341-3     Document Type: Article

References (30)

1. Leishmania vaccines: Old and new
2. Vaccines against leishmaniasis
3. Leishmaniasis: Immunological and clinical aspects and vaccines in Venezuela
4. The regulation of immunity to Leishmania major
5. Resolution of cutaneous leishmaniasis: Interleukin 12 initiates a protective T helper type 1 immune response
6. Expression cloning of a protective Leishmania antigen
7. Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major
8. Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes
9. Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis
10. Recombinant vaccinia viruses expressing gp46/M-2 protect against Leishmania infection
11. Stimulation of human T lymphocytes by Leishmania lipophosphoglycan-associated proteins
12. The kinetoplastid membrane protein 11 of Leishmania donovani and African trypanosomes is a potent stimulator of T-lymphocyte proliferation
13. The humoral immune response to the kinetoplastid membrane protein 11 in patients with American leishmaniasis and Chagas disease: Prevalence of IgG subclasses and mapping of epitopes
14. Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63
15. Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induced Th1 cells and protective immunity against leishmaniasis
16. Toxoplasma gondii: Isolation and preliminary characterization of temperature-sensitive mutants
17. Live and killed vaccines against toxoplasmosis in mice
18. Intact immune defenses are required for mice to resist the ts-4 vaccine strain of Toxoplasma gondii
19. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice
20. Cloning of genes and expression and antigenicity analysis of the Leishmania infantum KMP-11 protein
21. Transient transfection and expression in the obligate intracellular parasite Toxoplasma gondii
22. Processing of Toxoplasma ROP-1 protein in nascent rhoptries
23. Gene replacement in Toxoplasma gondii with chloramphenicol acetyltransferase as selectable marker
24. + T lymphocytes in IFN-γ production and protective immunity induced by an attenuated Toxoplasma gondii vaccine
25. Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major
26. The protozoan parasite Toxoplasma gondii targets proteins to dense granules and the vacuolar space using both conserved and unusual mechanisms
27. Listeria monocytogenes as a short-lived delivery system for the induction of type 1 cell-mediated immunity against the p36/LACK antigen of Leishmania major
28. Invasion, control, and persistence of Leishmania parasites
29. + T cell-dependent protective immunity against malaria